Yakup Ergün

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Yakup Ergün
Sep 7, 2024, 05:34 | Blog
Survival Outcomes in Real-World Settings After Alternative Pembrolizumab Dosing for NCSLC
Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X, about recent paper…
Aug 29, 2024, 03:10 | Insight
ASCO Guideline Clinical Insights: Metastatic Hormone Receptor–Positive Breast Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X: "Targeted Therapies, Sequencing Strategies, and…
Aug 9, 2024, 02:14 | Insight
T-DXd in HER2 - Expressing Biliary Tract Cancer
Yakup Ergün, Medical Oncologist at Batman World Hospital, shared on X about a recent paper…
Aug 8, 2024, 20:04 | Insight
Yakup Ergün: Is completion axillary lymph node dissection necessary for adjuvant CDK4/6 inhibitors?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: “SENOMAC post-hoc analysis: Is…
Jul 28, 2024, 06:21 | Blog
Yüksel Ürün: The terms 'manageable' and 'acceptable' can be misleading
Yüksel Ürün shared a post by Yakup Ergün, Medical Oncologist at Antalya City Hospital, on…
Jul 27, 2024, 14:16 | Insight
Foritinib in advanced ROS1-rearranged NSCLC in China
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Jul 27, 2024, 13:03 | Blog
Yakup Ergün: Can we truly label a study with Grade 5 toxicity as 'acceptable' or 'manageable'?
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Can we truly label…
Jul 25, 2024, 07:47 | Insight
HER2-targeted therapies beyond breast cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Jul 21, 2024, 21:49 | Blog
Dose-Dense vs Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X, about a recent paper…
Jul 10, 2024, 16:42 | Blog
Yakup Ergün: The effects of 960 mg sotorasib
Tejas Patil, Thoracic oncologist CU Cancer Center, shared a post by Yakup Ergün, Medical Oncologist at Antalya…
Jul 8, 2024, 19:24 | Blog
Yakup Ergün: PRODIGE 23: Long-term results
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared insight about a study by Thierry…
Jun 22, 2024, 13:55 | Insight
"Why do patients with cancer die?" by Adrienne Boire et al.
Recently, Thomas R. Cox, Lab Head of Matrix and Metastasis Lab, shared a post on…
Jun 22, 2024, 13:36 | Blog
Primary Results From AMEERA-5
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Amcenestrant Plus Palbociclib vs Letrozole…
Jun 20, 2024, 16:17 | Blog
Yakup Ergün: My observations over the past few years as a reviewer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X: "My observations…
Jun 16, 2024, 15:51 | Insight
Yakup Ergün: CF, DCF, or CF combined with radiotherapy for squamous cell oesophageal cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X: "CF, DCF,…
Jun 12, 2024, 08:34 | Insight
Yakup Ergün: According to Petra Jagust et al. RET is crucial in the mechanism and etiology of BC brain metastases
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X: “RET…
Jun 3, 2024, 12:44 | Insight
Yakup Ergün: Adding LCT does not improve survival in oligometastatic NSCLC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X: "NRG-LU002:…
Jun 2, 2024, 09:09 | Societies
15 Posts From ASCO24 Day 2 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
May 31, 2024, 17:02 | Insight
Yakup Ergün: A guide where we can find answers to every question about aBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 28, 2024, 16:11 | Insight
Yakup Ergün: This is the most comprehensive review I have seen so far
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 26, 2024, 13:42 | Insight
Some of the highlights while waiting for ASCO24 by Yakup Ergün
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 26, 2024, 10:50 | Opinion
Yakup Ergün: The policy of some journals to collect accepted letters under a single heading is quite unfair
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared on X: “The policy…
May 26, 2024, 08:25 | Blog
Paolo Tarantino: Looking forward to presenting this analysis of T-DXd in 1500 patients with MBC
Paolo Tarantino shared a post by Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital,…
May 25, 2024, 01:35 | Insight
Yakup Ergün: An excellent review on the gonoadotoxicity of new anticancer agents
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared on X/Twitter: "Assessing risks…
May 23, 2024, 09:20 | Blog
Yakup Ergün Summarizes Final Results of RIGHT Choice
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on X:…
May 21, 2024, 15:41 | Insight
Yakup Ergün: A valuable retrospective study on PD-L1 alteration after NAC in TNBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
Apr 9, 2024, 09:20 | Insight
Yakup Ergün: Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases - SENOMAC trial
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
Aug 14, 2023, 17:14 | Insight
Yakup Ergün: Breast-cancer screening gets a boost from Artificial Intelligence (AI)
In a Twitter post by Yakup Ergün, Medical Oncologist, it says: "Breast-cancer screening gets a…
All: 28 Posts: 1 - 100
Special Coverage